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Abstract
The global AIDS pandemic continues to expand and in some regions of the world, such as southern Africa, the prevalence of
HIV-1 infection exceeds 20%. The devastating spread of the virus in young women in these countries appears
disproportional to overall risk of infection. Regions with high prevalence of HIV-1 are often also highly endemic for other
pathogenic viruses including HSV, CMV and HTLV. We propose that acquisition by HIV-1 of the envelope glycoproteins of
other viruses, in a process we call ‘‘natural pseudotyping,’’ expands the cellular tropism of HIV-1, enabling it to infect female
genital epithelial cells directly and thereby dramatically increasing risk of infection during sexual intercourse. In this proof-
of-concept study, we demonstrate that when HIV-1 co-infects T cells along with the gammaretrovirus xenotropic murine
leukemia virus-related virus (XMRV), progeny HIV-1 particles are produced capable of infecting primary vaginal, ectocervical
and endocervical epithelial cells. These cell types are normally resistant to HIV-1 infection. Infection of primary genital cells
was neutralized by antisera against the XMRV glycoprotein, confirming that infection was mediated by the XMRV
glycoprotein acquired through pseudotyping of HIV. Inhibition by AZT showed that active replication of HIV-1 occurred in
these cells and ruled out non-specific endocytic uptake of the virus. These results demonstrate that natural pseudotyping
can expand the tropism of HIV-1 to include genital epithelial cells and have potential implications for sexual transmission of
the virus.
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Introduction
The HIV/AIDS pandemic is primarily sustained by heterosex-
ual transmission of HIV-1 and more than half of all new infections
occur in young women. The prevalence of HIV-1 in some regions
of Africa has exceeded 20% [1] and in sub-Saharan Africa,
females constitute 75% of infected individuals between the ages of
15 and 24. In the nine countries in southern Africa most affected
by HIV-1, prevalence among these young women was on average
about three times higher than among men of the same age [2].
The virus is spreading among women at a rate that cannot be
explained by other non-viral sexually transmitted diseases (STDs),
sexual practices, including frequency and type of sex, or unusual
virus characteristics [1–3]. While the overall risk of HIV
transmission during heterosexual intercourse has been estimated
to be 1 in 1000 to 1 in 200 [4,5], anecdotal and clinical reports
exist of ‘‘super spreaders’’ of HIV-1 who appear able to transmit
HIV-1 to their sex partners quite efficiently [6–8].
The cellular tropism of retroviruses is determined by the cell
receptor specificity of their envelope glycoproteins. In the case of
HIV-1, the attachment protein gp120 binds specifically and
sequentially to CD4 and chemokine receptors, primarily CXCR4
and CCR5 and this limits the tropism of HIV-1 to CD4+ T cells,
macrophages, and dendritic cells [9–17]. Retroviruses such as
HIV-1 are capable of incorporating envelope glycoproteins of
other viruses. In a process known as pseudotyping, the envelope
gene (gp160) of HIV-1 is deleted from the viral genome which is
then expressed in cells expressing the envelope glycoprotein from
other viruses. Importantly, the cellular tropism of the pseudotyped
virus is that of the virus from which the envelope glycoprotein is
derived. Thus, VSV G-pseudotyped HIV-1, like VSV, can infect
many cell types, including epithelial cells. In vivo, it is well known
that individuals infected by HIV-1 often harbor infection by a
number of other viruses [18–23]. Co-infection of HIV-1 permis-
sive cells (CD4+ T cells, macrophages, and dendritic cells) by HIV-
1 and other viruses may allow HIV-1 to acquire the envelope
glycoprotein (and cellular tropism) of the co-infecting virus. We
refer to this phenomenon as ‘‘natural pseudotyping’’ to distinguish
it from pseudotyping through molecular genetic techniques as
described above. We propose that this process may represent a
mechanism that profoundly increases the likelihood of sexual
transmission of HIV-1.
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The mucosal surfaces of lower regions of the female reproduc-
tive tract, comprised of squamous or columnar epithelial cells,
represent a mechanical barrier to HIV-1. These cells do not
express CD4 or CCR5 and are resistant to HIV-1 infection. How
HIV-1 interacts with and crosses the genital mucosal epithelium to
infect immune cells is incompletely understood. If HIV-1 acquires
glycoproteins from epithelial cell-tropic viruses by co-infection
with such viruses and these pseudotyped viruses are released into
seminal fluid, direct infection of genital epithelial cells by HIV-1
could occur. Once HIV-1 has infected epithelial cells, spread to
intraepithelial T cells, macrophages or dendritic cells followed by
trafficking of these cells to lymph nodes would result in systemic
infection. Therefore, we propose that natural pseudotyping may
represent a mechanism that facilitates sexual transmission of HIV-
1.
Here we report evidence to support the natural pseudotyping
hypothesis in a model system employing xenotropic murine
leukemia virus-related virus (XMRV), as the co-infecting virus.
XMRV is a gammaretrovirus that was originally believed to be
associated with prostate cancer and chronic fatigue syndrome, but
recent reports indicate it arose as a result of a recombination event
between two endogenous murine leukemia viruses after xeno-
transplantation of cells in nude mice [24,25]. We chose XMRV as
a model for natural pseudotyping with HIV-1 because of its broad
cellular tropism, which overlaps with that of HIV-1 (T cells and
macrophages). Furthermore, we demonstrated that lipid rafts play
a role in the biology of this virus [26]. This observation further
suggested XMRV as a good model virus for studying natural
pseudotyping of HIV-1 given that HIV-1 assembly and release
also occurs at lipid rafts [27–34], We explored whether XMRV
and HIV-1 co-infection in T cells results in pseudotyped HIV-1
capable of infecting epithelial cell lines and primary cells from
female lower genital tract epithelium. The results confirm that
natural pseudotyping of HIV-1 occurs and expands its tropism to
include genital epithelial cells.
Materials and Methods
Cell Lines
The LNcap cell line was purchased from American Type
Culture Collection (Rockville, MD). LNcap cells and CEMX174
cells were maintained in cRPMI [RPMI 1640 (Gibco-BRL/Life
Technologies, Gaithersburg, MD) supplemented with L-gluta-
mine, 10 mM HEPES (pH 7.2), and 10% fetal bovine serum (FBS)
(Hyclone, Logan, UT)]. CD4+ T cells were isolated from PBMC
by negative selection with magnetic beads (Miltenyi Biotec) and
were cultured in RPMI supplemented with 10% FCS (HyClone),
100 mg/mL streptomycin, and 100 U/mL penicillin. CD4+ T cells
were activated with phytohemagglutinin (PHA) (3 ug/ml) in the
presence of interleukin-2 (IL-2) (20 U/mL; Roche Applied
Science) for 72 hrs. Human vaginal epithelial cell line VK2
(ATCC2616), ectocervical epithelial cell line Ect1/E6E7
(ATCCCRL1614) and endocervical cell line End1/E6E7
(ATCCCRL2615) were obtained from the American Type
Culture Collection. These cells were selected because they were
generated from normal vaginal, ectocervical and endocervical
mucosal tissues; VK-2 cells and Ect1/E6E7 cells are derived from
squamous epithelial cells lining the vagina and ectocervix
respectively. End1/E6E7 cells are derived from simple columnar
endocervical epithelium cells [35]. VK2, Ect1/E6E7 and End1/
E6E7 cells were maintained in keratinocyte serum-free complete
media (KSFM) (Gibco, Grand Island, NY).
Primary Epithelial cells
Vaginal and cervical tissues from pre-menopausal women aged
18–44 years undergoing hysterectomy and/or vaginal vault repair
were processed within 2–4 h of completion of surgery. The
experimental protocol including collection of discarded tissue had
full University of California, Davis, Institutional Review Board
(IRB) approval. Signed informed consent forms were obtained
from donors for all tissues used in this study. Tissues were collected
in Human Vaginal Epithelial Cell Culture Complete Growth
Media containing 0.25 mg/ml fungizone (Celprogen, San Pedro,
CA). The underlying connective stromal tissue was carefully
dissected away from epithelial layers. The tissue was cut into 161-
cm pieces and placed with the epithelium surface facing down in
12-well culture plates to allow epithelial cell migration from the
tissues. EpiGRO Human Epidermal Keratinocyte Complete
Media (Millipore, CA) was added to each well. The medium
was changed every other day until an epithelial monolayer was
formed (3 to 7 days); the cells were then subjected to subculture
and were expanded for cryopreservation and for use in HIV-1
infection studies. Cultures of human primary vaginal epithelial
cells (Celprogen, CA) and human primary cervical epithelial cells
(Cell Application, CA) were also purchased and maintained in
medium provided by the cell vendor following vendor protocols.
HIV-1 and XMRV infection of T cells
HIV-1 IIIB, HIV-1Bal and XMRV virus stocks were prepared
from Jurkat cells, PM1 cells and LNcap cells, respectively. Culture
supernatants from infected cells were collected, centrifuged at
1,0006g to remove cell debris, filtered through a 0.45-mm filter,
and concentrated by ultracentrifugation at 100,0006g for 1 hr.
The pelleted virus was resuspended in RPMI1640 containing 10%
FBS, aliquoted, and stored at 280uC. The viral titers were
measured by anti-p24 Gag ELISA (HIV) or by RT activity assay
(HIV, XMRV) with a commercial kit (Cavidi Tech AB, Uppsala,
Sweden). CEMX174 or primary CD4+ T cells were infected with
XMRV and HIV-1 simultaneously or infected with XMRV first,
followed by superinfection with HIV-1 by spinoculation as
described previously (36). Cells infected with either virus alone
were included as controls. Twenty-four hrs after exposure to HIV-
1, the input virus was removed by thorough washing. The virus-
containing supernatants were collected every two days for the next
4–8 days. The supernatants were centrifuged at 1,0006g to
remove cells and cell debris, filtered through a 0.45-mm filter and
then the viruses were pelleted by ultracentrifugation at 100,0006g
through a 20% sucrose cushion and stored at 280uC. The viral
titers were measured by anti-p24 Gag ELISA (HIV-1) or by
quantitative RT PCR (qRT-PCR) (HIV-1, XMRV). Western blot
analysis was performed to measure both XMRV and HIV-1 viral
release into supernatants, as described previously [37].
Viral infection of epithelial cells and immunofluorescence
staining
Epithelial cells were grown on coverslips or 35-mm glass-bottom
dishes to a density of 1 to 56104 cells/35 mm dish. Cells were
exposed to the virus-containing supernatants or purified virus from
HIV-1-infected, XMRV-infected, or HIV-1/XMRV co-infected
T cells for 24 hrs; the input virus was then removed by thorough
washing. For cell-associated infection, infected CEMX174 cells
and the mock infected CEMx174 control cells were treated with
100 mg/ml of mitomycin C at 37uC for 1 hr and washed. The
CEMx174 cells and primary epithelial cells were then co-cultured
for 2 days at a ratio of 1:1. The non-adherent CEMx174 cells were
removed by washing the epithelial monolayers three times with
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PBS and growth media was then added back to the epithelial cells.
For both cell free and cell-associated infection, the epithelial cell
supernatants were harvested 5 days post-infection. The adherent
epithelial cells were then fixed with 2% paraformaldehyde for
30 minutes and suspended in blocking buffer (5% normal goat
serum and/or 1% mouse serum, 3% BSA in PBS), before
permeabilization with 0.2% saponin. Primary antibody against
HIV-1 Gag p24 (KC57-FITC, Beckman Coulter, Inc., Fullerton,
CA) was incubated with the cells for 1 hr and the cells were then
washed. For double-staining in primary epithelial cells, the cells
were first incubated with anti-Cytokeratin 19 primary antibody
(Sigma, CA). Secondary antibody binding and amplification of
signal was accomplished with Cy3 goat anti-mouse IgG. Following
incubation with secondary antibody, the cell monolayer was then
incubated with FITC-conjugated anti-HIV Gag antibody as
described above. Additional antibodies were also used in the
characterization of primary epithelial cells. These included: anti-
Cytokeratin 18, anti-Cytokeratin 8 (Sigma, CA); anti-XPR1
(Abcam, CA); anti-CD45, anti-CCR5, anti-CXCR4, and anti-
CD4 (BD Biosciences, CA). After staining, the cells were examined
with a Nikon TE2000 C1 laser scanning confocal microscope
(Nikon Instruments, NY) or Olympus FV1000 laser scanning
confocal microscope (Olympus, USA).
Quantitative analysis of viral RNA
XMRV and HIV-1 viral RNA in supernatants from infected
cells was isolated with QIAamp Viral RNA kits (Qiagen, CA) and
subjected to reverse transcription with SuperScript III cDNA
synthesis kits (Invitrogen, Grand Island, NY, STATE). Real-time
PCR was performed using iQSYBR green supermix (Bio-Rad,
Hercules, CA) (XMRV primers: 59-AACCGTATGGCAGAT-
CAAGC-39 and 59-TTTGCCTTGTAGGACCCAAT-39) (HIV-1
Gag Primers: 59-GGA GCT AGA ACG ATT CGC AGTTA-39
AND 59-GGT TGT AGC TGT CCC AGT ATT TGTC-39).
Standard curves were generated using viral stocks with known
genome copy numbers. Real-time PCR assays were performed in
an iCycler (BioRad) with iQ Sybr green supermix (Bio-Rad). All
analyses were performed at least three times, with triplicate
samples in each experiment.
Zidovudine (AZT) treatment and antibody neutralization
assay
Epithelial cells were plated and cultured overnight as described
above. HIV-1-infected, XMRV-infected or HIV-1/XMRV co-
infected CEMX174 cells or free virus from these infected cells
were pre-incubated for 1 hr at 37uC with 10 mM of AZT or with
dilutions of polyclonal goat anti-Friend MLV antibody (ATCC
catalog #VR1537AS-Gt). Normal Goat serum and HIV-1 gp41
monoclonal antibody 2F5 (The NIH AIDS Reagent Program)
served as controls. The viral mixtures were then added to
epithelial cells and 24 hr later input virus or non-adherent cells
were removed by washing 3 times with PBS. After adding back
growth medium, the epithelial cells were incubated for another
four days and immunofluorescence staining was performed to
detect HIV-1 Gag expression. Culture supernatants were collected
to measure XMVR and HIV-1 RNA by q-PCR or HIV-1 by Gag
ELISA (HIV).
Data analysis
All experiments were repeated a minimum of three times.
Comparisons between two groups were performed by Student’s t
test.
Ethics Statement
None of the viruses used in these studies were collected directly
from infected patients. They were obtained from collections
maintained by the National Institutes of Health AIDS Reagent
Program.
Results
HIV-1 produced in XMRV and HIV-1 co-infected CD4+ T
cells infects epithelial cells
We sought to determine if natural pseudotyping of HIV-1
occurs when it co-infected the same cells along with the
gammaretrovirus XMRV. In previous studies we demonstrated
the involvement of cholesterol and lipid rafts in the biology of
XMRV [26] as previously shown for HIV-1. XMRV utilizes the
XPR1 membrane protein as its receptor; because this protein is
widely expressed on cells of multiple lineages, the cellular tropism
of the virus is broad and includes epithelial cells. The tropism of
XMRV overlaps with that of HIV-1 and XMRV infection of
human primary T cells has been demonstrated [38]. XMRV was
thought to be associated with human disease at the time we began
our studies but was subsequently shown to be a laboratory artifact
[25]. To demonstrate that HIV-1 and XMRV can efficiently
replicate and be released from co-infected cells, we infected
CEMX174 cells and primary CD4+ T cells with XMRV, then
superinfected with HIV-1 IIIB. In some experiments the cells were
infected with both viruses simultaneously. Cells infected with
either virus alone and uninfected cells served as controls. Twenty-
four hrs after adding HIV-1, the input virus was removed by
extensive washing and HIV-1 and XMRV production was
assessed after 3 additional days of culture. As shown in
Figure 1A, western blot analysis confirmed that HIV-1 was
released from HIV-1-infected and XMRV/HIV-1 co-infected
cells. Similarly, XMRV p30 was detected in the supernatants from
XMRV-infected and HIV-1/XMRV co-infected cells.
We also performed real-time PCR analysis to quantify the
released XMRV and HIV-1 RNA. Results showed that XMRV/
HIV-1 co-infected cells released both HIV-1 and XMRV,
approximately 2–36109 RNA genome copies/mL for each virus.
Interestingly, both HIV-1 and XMRV release from co-infected
cells was three- to four-fold higher compared with virus release
from cells infected with HIV-1 or XMRV alone, respectively
(Figure 1B).
These data indicate that both HIV-1 and XMRV can replicate
and be released efficiently from co-infected T cells. If XMRV
glycoprotein is acquired by HIV-1 virions produced in HIV-1/
XMRV co-infected T cells, these HIV-1 particles should have
acquired XMRV tropism and be able to infect epithelial cells
unlike non-pseudotyped HIV-1. To determine if this was true, we
used LNcap cells, an epithelial cell line derived from prostate
carcinoma that is known to support XMRV replication. We
exposed LNcap cells to supernatants from the HIV/XMRV co-
infected cells and from cells infected with either HIV-1 alone or
XMRV alone. After 5 days, we examined the cells for HIV-1
infection by confocal immunofluorescence microscopy after
staining with a MAb against HIV-1 Gag. As showed in
Figure 2A (left two panels), LNcap cells were infected by HIV-1
from XMRV/HIV-1 co-infected cells but not by HIV-1 produced
alone (Figure 2A, right panel).
To assess whether LNcap cells were productively infected by
HIV-1, LNcap cells were infected with progeny viruses from HIV-
1/XMRV co-infected T cells in the presence of reverse
transcriptase inhibitor azidothymidine (AZT). As shown in
Figure 2B, confocal immunofluorescence microscopy showed that
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HIV-1 infection of LNCap cells could be completely blocked by
the antiretroviral drug. This observation was confirmed by real
time PCR analysis. HIV-1 viral RNA was only detected in
supernatants of cells infected with progeny HIV-1 from XMRV/
HIV-1 co-infected T cells (Figure 2C). XMRV replication was
confirmed in LNcap cells infected with progeny viruses from both
XMRV/HIV-1 co-infected cells and XMRV-infected cells
(Figure 2D). AZT treatment not only blocked HIV-1 infection
(Figure 2C), but also blocked XMRV infection (Figure 2D),
consistent with previous observations [39].
HIV-1 infection of epithelial cells is inhibited by
neutralizing anti-MLV antibody
The data above showing infection of epithelial cells by HIV-1
co-produced with XMRV indicated that co-infection results in
HIV-1 bearing the XMRV gp70 glycoprotein. To provide direct
evidence that infection of epithelial cells by HIV-1 co-produced
with XMRV was mediated through the XMRV glycoprotein, we
performed infection assays with a neutralizing polyclonal goat
antibody produced against MLV. This polyclonal antiserum has
been shown to be highly cross-reactive with XMRV and to
neutralize XMRV over a wide dilution range. It does not
neutralize HIV-1 [40]. First, we confirmed that XMRV infection
is neutralized by the antibody. Progeny viruses from CEMx174
cells co-infected with HIV-1 and XMRV, infected with HIV alone
and infected with XMRV alone were incubated with dilutions of
heat-inactivated anti-MLV polyclonal sera. After 1 hr at 37uC, the
mixtures were added to LNcap epithelial cells. The input virus was
removed after 24 hrs and viruses released into the supernatants
were analyzed by real-time PCR 5 days post-infection. As shown
in Figure 3A, the XMRV viral RNA detected in supernatants was
decreased by 4 to 5 logs in the presence of polyclonal antisera
against MLV at dilutions of 1:100 and 1:300. This was true for
control XMRV as well as XMRV co-produced with HIV-1.
Infection was not blocked by normal goat serum diluted 1:100.
These data confirmed that neutralizing antibody against MLV
effectively neutralized XMRV infection as previously reported
[40].
We tested the effect of the anti-MLV antisera on infection of
epithelial cells by HIV-1 co-produced with XMRV. The same
LNcap cells that were infected with progeny viruses from HIV-1/
XMRV co-infected T cells in the presence of the anti-MLV sera
were fixed and stained for HIV-1 p24. As shown in Figure 3B, no
HIV-1 positive cells were seen when virus was added in the
presence of anti-MLV polyclonal sera at a 1:300 dilution. A few
HIV-1 infected cells could be detected at a polyclonal antiserum
dilution of 1:900. HIV-1 positive cells were easily detected when
virus was treated with control serum. Consistent with the results
from confocal immunofluorescence microscopy, we could not
detect HIV-1 viral RNA in culture supernatants from cells exposed
to pseudotyped HIV-1 pretreated with anti-MLV sera at a dilution
of 1:300 (Figure 3C). Partial reduction of HIV-1 RNA was
observed at an anti-MLV antiserum dilution of 1:900 (Figure 3C).
As expected no HIV-1 viral RNA was detected in supernatants
from cells exposed to progeny viruses from cells infected with only
HIV-1 or XMRV (Figure 3C). As previously reported, HIV-1
infection of T cells was not blocked by the anti-MLV antiserum
(not shown). These data indicate that infection of epithelial cells by
HIV-1 co-produced with XMRV is mediated by the XMRV
glycoprotein.
HIV-1 produced from XMRV and HIV-1 co-infected CD4+
T cells infects vaginal and cervical epithelial cell lines
The above results showed that HIV-1 co-produced with
XMRV could infect an epithelial cell line. To determine whether
female genital epithelial cells could also be directly infected by
Figure 1. CEMx174 cells support both XMRV and HIV-1 replication. A. Supernatants from CEMx174 cells infected with the viruses indicated
were collected 3 days post-infection and subjected to Western blot analysis with goat anti-serum against MLV Gag (top panel) or with an anti-HIV-1
Gag mAb (bottom panel). Data are representative of 5 independent experiments. B. Supernatants from CEMx174 cells infected with the viruses
indicated were subjected qPCR to quantify XMRV and HIV-1 RNA genomes. Values represent an average of 5 experiments.
doi:10.1371/journal.pone.0101367.g001
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Figure 2. LNcap epithelial cell line is susceptible to infection by HIV-1 co-produced with XMRV. A. Visualization of HIV-1 infection in
epithelial cells using immunofluorescence staining with anti-HIV Gag monoclonal antibody. LNcap cells were exposed to culture supernatants from
CEMX174 cells infected with indicated viruses. Cells were fixed and stained for HIV-1 Gag expression 5 days after exposure to the viral supernatants.
Green fluorescence (FITC) indicates HIV-1 Gag expression. Green fluorescence merged with corresponding bright field images are shown in the
bottom panels. An enlarged view of cells exposed to HIV-1 co-produced with XMRV is shown in the second panel from the left. B. AZT inhibits HIV-1
infection of epithelial cells. LNcap cells and progeny viruses from HIV-1/XMRV co-infected CEMX174 cells were pretreated with AZT or with medium
alone. The virus preparations were then added to the cells and the input virus was removed after 24 hrs. The cells were then cultured for an
additional four days in medium alone or medium containing AZT as outlined in Materials and Methods. The cells were then fixed and stained for HIV-
1 Gag expression. Cells infected in the absence of AZT are shown on the left. The corresponding bright field image is shown in the bottom panels.
Bar = 10 mm. Data are representative of 5 independent experiments. C. HIV-1 RNA in the supernatants of the same LNcap cells from (B.) infected in
the presence or absence of AZT was quantified by qRT-PCR. D. XMRV RNA in the supernatants of the infected LNcap cells was quantified by qPCR.
The input viruses were supernatants from CEMx174 cells infected as indicated. For (C) and (D) the data shown represent the mean 6 standard
deviation from five independent experiments. **p,0.001, infection in the absence vs presence of AZT.
doi:10.1371/journal.pone.0101367.g002
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HIV-1, we employed the vaginal epithelial cell line VK2, derived
from normal vaginal tissue. VK2 cells were exposed to progeny
viruses from HIV-1/XMRV co-infected T cells for 24 hrs, washed
thoroughly, and cultured for an additional 4 days. Cells were then
fixed and stained for HIV-1 Gag protein expression. HIV-1
infection was detected in VK2 cells exposed to progeny viruses
Figure 3. Inhibition of HIV-1 infection of epithelial cells by neutralizing anti-MLV polyclonal antiserum. A. Anti-MLV polyclonal
antibody neutralizes XMRV infection in a dose-dependent manner. Progeny viruses from CEMX174 cells infected with HIV-1 and/or XMRV were pre-
incubated with the indicated dilutions of anti-MLV polyclonal serum at 37uC for 1 hr before addition to LNcap epithelial cells. XMRV released into the
supernatants of infected LNcap cells was quantified by qRT-PCR. pAb=Anti-MLV polyclonal antibody; Con. Serum=normal goat serum diluted 1:100.
The input viruses used to infect producer CEMx174 cells are indicated at the bottom. The data shown represent the mean6 standard deviation from
three independent experiments. B. Immunofluorescence analysis of HIV-1 infection in LNcap cells in the presence or absence of anti-MLV neutralizing
antibody. The same LNcap cells infected with progeny viruses from HIV-1/XMRV co-infected cells (shown in A) in the presence of indicated dilutions
of anti-MLV neutralizing pAb or control serum were stained for HIV-1 Gag (green). The corresponding bright field image for each panel is shown on
the right. Bar = 10 mm. Images are representative of three independent experiments. C. HIV-1 viral RNA in supernatants of from the same infected
LNcap cells in (B) was quantified by qRT-PCR. The input virus used to infect producer cells and the dilutions of neutralizing or control sera are
indicated. The data shown represent the mean 6 standard deviation from three independent experiments. *, p,0.05; **, p,0.001, control serum vs
anti-MLV pAb.
doi:10.1371/journal.pone.0101367.g003
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from HIV-1/XMRV co-infected T cells (Figure 4A). No HIV-1-
infected cells were detected in the presence of AZT, confirming
active virus replication in VK2 cells (Figure 4A, right panel). We
did not detect HIV-1 infection in VK2 cells exposed to progeny
viruses from cells infected with HIV-1 alone or XMRV alone or to
mock virus (Figure 4B). Q-RT-PCR showed HIV-1 RNA release
from VK2 cells exposed to progeny viruses from HIV-1/XMRV
co-infected T cells but not virus from control cells (Figure 4C).
XMRV viral RNA was detected in supernatants of VK2 cells
infected with progeny viruses from both HIV-1/XMRV co-
infected T cells and XMRV-infected T cells (Figure 4D).
Both vaginal and cervical epithelia are considered as possible
sites for viral entry in sexual transmission of HIV-1 in women.
Therefore we tested XMRV-pseudotyped HIV-1 for infection of
cervical epithelial cell lines Ect1/E6E7 and Endo1/E6D7. These
cell lines were generated from the same normal donor as VK2 cells
by in vitro HPV E6/E7 immortalization of primary epithelial cells
from the ectocervix and endocervix, respectively. These cell lines
have been shown to maintain morphologies and phenotypes
consistent with their respective tissue origins [35]. HIV-1 Gag
specific immunostaining and confocal microscopy showed HIV-1
infection of both Ect1/E6E7 and End1/E6E7 cells when exposed
to HIV-1 co-produced with XMRV (Figure S1A, S1B). HIV-1
Gag was not observed in the AZT treated cells and this confirmed
active virus replication (Figure S1C, S1D, first panel). No HIV-1
Gag expression was detected in cells exposed to control HIV-1,
XMRV or mock virus (Figure S1C, S1D, three panels on the
right). These data showed that HIV-1 co-produced with XMRV
was able to infect endocervical and ectocervical epithelial cell lines.
We also tested HIV-1 infection in HeLa cells, a cervical cancer
cell line. The cells were exposed to progeny virus from HIV-1 and
XMRV co-infected T cells for 24 hrs and after washing away the
input virus the cells were cultured for 5 days. The cells were then
fixed and stained for HIV-1 Gag expression. As shown in
Figure 5A, clusters of HIV-1 positive cells could be easily detected.
We used flow cytometry to quantify the percentage of cells that
were HIV-1 positive. The data indicated that less than 1% of the
cells were HIV-1 infected (Figure S2A), consistent with a low
frequency of pseudotyped HIV-1 particles. HIV-1 infection in
HeLa cells was also assessed by HIV-1 p24 ELISA analysis of cell
supernatants. HIV-1 was detected in supernatants from HeLa cells
exposed to progeny virus from HIV-1/XMRV co-infected T cells
(Figure 5D). In contrast, HIV-1 infection was not observed in
HeLa cells exposed to virus released from T cells infected with
XMRV or HIV-1 alone (Figure 5C, D). The infection of HeLa
cells by HIV-1 was blocked by AZT and neutralizing anti-MLV
sera (Figure 5B, D). Control non-immune serum and a well-
characterized neutralizing anti-HIV-1 gp120 antibody 2F5 (4 mg/
ml) had no effect on infection of HeLa cells by pseudotyped HIV-1
(Figure 5D). To confirm 2F5 neutralization of HIV-1, we
performed a parallel experiment in TZM-bl cells, which are
HeLa cells expressing endogenous CXCR4 that have been stably
transfected with CD4 and CCR5. These cells efficiently support
HIV-1 infection and replication [41]. HIV-1 produced in
CEMX174 cells was incubated for 1 hr with serial dilutions of
Figure 4. Pseudotyped HIV-1 infects epithelial cells derived from vagina. Immunofluorescence analysis of HIV-1 infection in VK-2. VK-2 cells
were infected with progeny virus from primary CD4+ T cells or CEMX174 and were stained for HIV-1 Gag expression 5 days post-infection. The input
virus used to infect producer T cells are as indicated. An enlarged view of epithelial cells exposed to progeny virus from HIV-1/XMRV co-infected
CEMX174 cells is shown (second panel). HIV-1 Gag expression is indicated by green fluorescence (FITC); green fluorescence merged to the
corresponding bright field image is shown in the bottom panels. B. Target epithelial cells were exposed to progeny viruses in the presence or
absence of AZT as indicated on the panels. Data shown are representative of six independent experiments. Bar = 10 mm. C and D, HIV-1 and XMRV
viral RNA in the supernatants of the same infected VK-2 cells as in (A) and (B) were quantified by qRT-PCR. The viruses used to infect producer cells are
shown on the X axis. The data shown represent the mean 6 standard deviation from three independent experiments.
doi:10.1371/journal.pone.0101367.g004
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Figure 5. Pseudotyped HIV-1 infects HeLa cells. (A, C) Visualization of HIV-1 infection in HeLa cells by immunofluorescence staining with FITC-
anti-HIV-1 Gag mAb. HeLa cells were exposed to progeny virus from CEMX174 cells infected with the indicated viruses and immunofluorescence
staining was performed with anti-HIV-1 Gag mAb 5 days post-infection. B, HeLa cells were exposed to progeny virus from HIV-1/XMRV co-infected
CEMX174 cells in the presence of AZT or anti-MLV polyclonal sera (1:300) and were then stained for HIV-1 Gag expression as above. Anti-Gag
fluorescence merged to the corresponding bright field images is shown in the bottom panels. D, HIV-1 p24 released into culture supernatants from
infected HeLa cells was measured by ELISA. The input virus used to infect producer CEMX174 cells and the treatment of progeny virus used to infect
HeLa cells are indicated on the X-axis (pAb 1:300, anti-MLV polyclonal sera at dilution 1:300; 2F5, a neutralizing anti-HIV gp120 MAb at concentration
of 4 mg/ml; Con. Serum, normal goat serum diluted 1:300; Medium, medium alone control). **, p,0.001, control serum vs treated samples. The data
shown represent the mean 6 standard deviation from three independent experiments.
doi:10.1371/journal.pone.0101367.g005
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2F5 MAb before adding the virus to the cells. Infection of TZM-bl
cells by HIV-1 was blocked by 2F5 at concentrations of 2 ug/ml
or higher (Figure S2B). These results confirm data shown above
indicating that HIV-1 infection in epithelial cells is mediated by
XMRV glycoprotein acquired by HIV-1 during co-infection with
XMRV.
XMRV pseudotyped HIV-1 infects primary female lower
genital epithelial cells
The human female lower genital tract is lined with two types of
mucosal epithelial cells, columnar and squamous. Columnar
epithelial cells form a single layer lining the surface of the
endocervix and stratified squamous epithelial cells form the
mucosal lining of the vagina and ectocervix. These epithelial cells
are the first cells that HIV-1 encounters in the female genital tract
and they provide a natural barrier to prevent HIV-1 transmission.
This barrier would be potentially ineffective if HIV-1 acquires the
glycoprotein of a virus with tropism for epithelial cells. We thus
sought to determine if HIV-1 co-produced with XMRV could
infect primary epithelial cells from the female lower genital tract.
To establish primary epithelial cell cultures, fresh human
endocervical, ectocervical and vaginal tissue were collected, cut
into 161 cm pieces and placed in culture in epithelial cell growth
medium. Epithelial cells began migrating into the culture vessels
after 2 days and migration peaked after 3 to 5 days (Figure S3A).
Monolayers of primary cells were well-established by day 7. The
endocervical columnar epithelial cells displayed a flattened cobble-
stone morphology as previously noted [35,42] (Figure S3B).
Immunostaining and confocal microscopy showed that endocer-
vix-derived epithelial cells expressed high levels of cytokeratins
CK8 and CK19 (Figure S3D), but low levels of involucrin. Vaginal
and ectocervical squamous epithelial cells displayed the expected
flattened, stretched morphology (Figure S3C). Immunostaining
and confocal microscopy indicated that these cells expressed high
levels of cytokeratin CK19. In contrast to the primary endocer-
vical cells, the squamous vaginal and ectocervical epithelial cells
expressed low levels of CK8 and high levels of involucrin (Figure
S3E). These data confirmed that the epithelial cells isolated from
normal tissues had marker phenotypes reflecting their tissue of
origin and our phenotyping data are consistent with those in a
previous report [35]. While both vaginal and cervical primary
epithelial cells expressed the HIV-1 co-receptor CXCR4, they did
not express hematopoietic markers including the HIV-1 receptor
CD4 and co-receptor CCR5 (Figure S3F, S3G).
The primary cells were exposed to progeny virus from
CEMx174 cells infected with HIV-1 alone (HIV), XMRV alone
(XMRV), or both HIV-1 and XMRV (HIV/XMRV). The input
of HIV-1 (RNA genomes) was kept constant and supernatant from
uninfected CEMx174 cells was used as a control (mock). We also
set up another control in which we pre-mixed equivalent amounts
of wild type HIV-1 and XMRV (both from singly infected cell
cultures) as found in progeny virus from co-infected cells and
exposed epithelial cells to the virus mixture. The progeny viruses
and virus mixtures were left on the cell monolayers for 24 hrs and
then removed by extensive washing. Fresh medium was then
added and the cells were cultured for an additional 4 days. Viral
infection in epithelial cells was detected by confocal immunoflu-
orescence microscopy after MAb staining with anti-HIV-1 Gag.
As shown in Figure 6A, we observed HIV-1 infection of primary
endocervical epithelial cells that were exposed to HIV-1 co-
produced with XMRV (green staining). Expression of the CK19
marker (red) confirmed that the infected cells were epithelial cells.
HIV-1 infection was inhibited by AZT or by pre-treatment of virus
with neutralizing anti-MLV polyclonal sera (Figure 6B, left two
panels). These data showed that productive HIV-1 infection of
endocervical cells occurred that required XMRV gp70-mediated
entry. No HIV-1 infection was detected in cells exposed to virus
from CEMX174 cells infected with HIV-1 alone or XMRV alone
(Figure 6B). Notably, mixtures of equivalent amounts of wild type
HIV-1 and XMRV did not lead to HIV-1 infection of the
epithelial cells. This indicated that XMRV infection of epithelial
cells did not lead to phenotypic or other changes that rendered the
cells permissive for HIV-1 infection (Figure 6B, right panel).
To further confirm the above observations, we examined virus
release in supernatants from infected endocervical epithelial cells
by quantitative PCR. Equivalent amounts of XMRV viral RNA
was released from endocervical cells exposed to XMRV, XMRV
and HIV-1 mixtures and progeny virus from HIV-1/XMRV co-
infected T cells respectively (Figure 6C). In contrast to XMRV,
HIV-1 viral RNA was only detected in supernatants from
endocervical epithelial cells that were exposed to progeny virus
from HIV-1 and XMRV co-infected cells. HIV-1 RNA was not
detected in supernatants from cells exposed to control HIV-1 or to
HIV-1 and XMRV mixtures (Figure 6D). XMRV infection was
inhibited by AZT and by anti-MLV polyclonal serum (Figure 6C).
PCR data confirmed that AZT treatment and anti-MLV
polyclonal serum inhibited HIV-1 infection in epithelial cells
exposed to progeny virus from HIV-1 and XMRV co-infected
cells (Figure 6D). We also determined whether primary vaginal
epithelial cells could be infected by naturally pseudotyped HIV-1.
The primary vaginal epithelial cells were exposed to progeny virus
from HIV-1/XMRV co-infected CEMX174 cells, from
CEMX174 cells infected with either virus alone, or from mock
infected control cells under the same conditions as described
above. At 5 days post-infection epithelial cells were subjected to
immunostaining for expression of HIV-1 Gag and the epithelial
marker CK19. The data revealed that primary vaginal epithelial
cells were infected by HIV-1 after exposure to progeny virus from
HIV-1/XMRV co-infected T cells (Figure 7A). This infection was
blocked by AZT and by neutralizing anti-MLV polyclonal serum
(Figure 7B, left two panels). No HIV-1 infection was detected in
the epithelial cells exposed to control HIV-1, XMRV or mock
virus (Figure 7B). Data obtained in primary ectocervical epithelial
cells was similar to that obtained in primary vaginal epithelial cells
(data not shown).
Published data indicates that sexual transmission of HIV-1 may
be mediated by cell-associated virus [43–45]. Therefore we
determined whether HIV-1 infection of primary epithelial cells
could be mediated by T cells co-infected with HIV-1 and XMRV.
Infected CEMX174 cells were pre-treated with mitomycin C and
the cells were then co-cultured with primary epithelial cells for 2
days. The non-adherent CEMx174 cells were removed by washing
and HIV-1 Infection in the epithelial cells was assessed by confocal
immunomicroscopy. The data revealed HIV-1 Gag protein
expression in primary endocervical epithelial cells that were co-
cultured with HIV-1/XMRV co-infected CEMX174 cells
(Figure 8A). The infection was blocked by AZT (Figure 8B). No
HIV-1 infection was detected in epithelial cells co-cultured with
CEMx174 cells infected with HIV-1 (C), XMRV (D) or mock
infected (E).
Previous reports suggest that sexual transmission of HIV-1 may
primarily involve strains that utilize CCR5 as co-receptor (R5
tropic) [46–47]. We repeated the above experiments with the R5-
tropic HIV-1 strain HIV-1BaL. The data showed that HIV-1BaL
co-produced with XMRV infected primary vaginal epithelial cells
(Figure S4). Thus our data indicates that both X4 and R5 HIV-1
strains can infect primary genital epithelial cells after natural
pseudotyping.
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Figure 6. Pseudotyped HIV-1 infects primary endocervical epithelial cells. (A, B) Visualization of HIV-1 infection in primary endocervical
epithelial cells by dual immunofluorescence staining with FITC-anti-HIV-1 Gag and anti-CK19 MAbs. Primary endocervical epithelial cells were
exposed to progeny viruses from infected CEMX174 cells and immunofluorescence staining was performed 5 days post-infection. Epithelial cells
exposed to virus in presence of AZT or anti-MLV polyclonal sera diluted 1:300 are shown as indicated (B, left two panels). HIV-1 Gag fluorescence is
shown as green and CK19 as red. The corresponding bright field images are shown on the right (A) or at the bottom (B). HIV-1 Gag staining merged
with CK19 staining and enlarged views of HIV-1 infected cells are shown in (A). C and D: XMRV RNA (C) and HIV-1 RNA (D) in supernatants from the
same infected primary endocervical epithelial cells from (A) and (B) above were quantified by qRT-PCR. The input virus used to infect producer
CEMX174 cells and the treatments are indicated on the X-axis of the graphs (pAb 1:300 = anti-MLV polyclonal sera at dilution 1:300; Control
serum=normal goat serum diluted 1:300; No serum= culture medium control). **, p,0.001, control serum vs indicated treatments. The data shown
represent the mean 6 standard deviation from three independent experiments. a, HIV-1 and XMRV from CEMX174 cells infected with each virus
alone were quantified and mixed at a ratio equal to the ratio of the two viruses in the progeny virus from HIV-1 and XMRV co-infected CEMX174 cells.
The virus mixture was then inoculated onto primary endocervical epithelial cells and immunostaining and qPCR was performed exactly as described
for progeny virus from co-infected CEMx174 cells.
doi:10.1371/journal.pone.0101367.g006
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Discussion
Phenotypic intermixing of viral components or pseudotyping is
a well-known phenomenon first described in the 1970’s [48,49]. In
the1990s, several studies indicated that when produced in cells
infected with a second virus, including HSV [57], VSV [58],
HTLV [59] and MLV [60], HIV-1 appeared to have an expanded
host range, suggesting that pseudotyped virions had formed.
Subsequent studies demonstrated that pseudotyped HIV-1 parti-
cles were produced when heterologous virus glycoproteins were
expressed in cells transfected with cloned HIV-1 DNA [50,61–63].
Pseudotyping is now routinely employed to target viral vectors for
gene delivery to specific cells and has been applied to a wide
variety of enveloped viruses including retroviruses, herpesviruses
and rhabdoviruses [50–54]. Our previous work demonstrated that
HIV-1 can acquire host proteins expressed in the membrane of
infected cells [55,56]. Cholesterol-rich membrane microdomains
(lipid rafts) are the sites for HIV-1 assembly and proteins present in
lipid rafts are selectively incorporated by the virus
[27,28,30,31,52]. Glycoproteins from other viruses that traffic to
lipid rafts are therefore predicted to be incorporated by HIV-1 and
published data confirm this prediction [51]. A further prediction of
these observations was that HIV-1 could be pseudotyped when it
co-infects cells with certain other viruses. We call this process
‘‘natural pseudotyping’’ to distinguish it from in vitro pseudotyping
achieved through molecular genetics techniques as described
above. In the current study we have used XMRV as a model
second virus to demonstrate that natural pseudotyping of HIV-1
occurs resulting in expansion of HIV-1 tropism to include primary
genital epithelial cells.
Figure 7. Pseudotyped HIV-1 infects primary vaginal squamous epithelial cells. (A, B) Dual immunofluorescence staining with FITC-anti-
HIV-1 Gag and anti-CK19 MAbs was performed on primary vaginal squamous epithelial cells which were exposed to progeny virus from infected
CEMX174 cells. HIV-1 Gag is shown as green and CK19 is shown as red. Corresponding bright field images are also shown as indicated. The input
viruses used to infect producer CEMX174 cells is indicated on the panels. Epithelial cells exposed to progeny virus in the presence of AZT or anti-MLV
polyclonal sera diluted 1:300 are shown in the left two columns in B.
doi:10.1371/journal.pone.0101367.g007
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During the past 30 years very few studies have examined the
significance or potential implications of natural pseudotyping in
viral transmission or pathogenesis. One potential reason why
natural pseudotyping studies have been largely discontinued is the
technical challenge of obtaining biochemical and ultrastructural
evidence to support phenotypic mixing of viral particles. Indeed,
several investigators have reported that they could not detect
pseudotyped HIV-1 particles after co-infecting cells with HIV-1
and HSV or other viruses [64–67]. In some of these studies [64],
virus capture or pull-down assays were often used to detect
pseudotyped HIV-1. In such assays an antibody against the
heterologous glycoprotein is used to precipitate pseudotyped HIV-
1 and then HIV-1 Gag protein or RNA is measured to confirm the
presence of HIV-1 particles. In other studies PCR was used to
measure HIV-1 replication in CD4-negative cells exposed to
progeny HIV-1 from co-infected cells. This more sensitive assay
also failed to detect HIV-1 infection in CD4-negative cells [65–
67]. If the frequency of pseudotyped HIV-1 particles is extremely
low, even PCR assays may not be sensitive enough to detect
infection by the pseudotyped virus. We used primary T cells and
CEMx174 cells as producer cells and found that the two co-
infecting viruses (HIV-1 and XMRV) replicated very well in these
cells increasing the likelihood that pseudotyping would occur. In
addition, we employed a biological (infection) assay to detect the
presence of pseudotyped HIV-1 since even a low frequency of
infection by pseudotyped viruses would result in amplification of
viral proteins and RNA. Our data showed that the frequency of
naturally pseudotyped HIV-1 was indeed low but sufficient to
result in measurable infection. To rule out endocytic uptake of
HIV-1 by these cells [68,69], we confirmed active replication with
the RT inhibitor AZT. Furthermore, neutralization by an MLV-
neutralizing antiserum showed that HIV-1 infection of epithelial
cells was mediated by the XMRV glycoprotein.
The risk of HIV-1 transmission during sexual intercourse has
been reported to be as low as 0.1% [4,5]. Genital epithelial cells do
not express receptors for HIV-1 and represent a mechanical
Figure 8. Pseudotyped HIV-1 infection of primary endocervical cells via cell-associated virus. Primary endocervical epithelial cells were
co-cultured for two days with an equal number of mitomycin C-treated CEMX174 cells infected with HIV-1 alone, XMRV alone or co-infected with
both viruses. After washing to remove non-adherent cells, dual immunofluorescence staining with FITC-anti-Gag and anti-CK19 MAbs was performed
on the adherent primary endocervical epithelial cells on day 5. Merged images confirmed that HIV-1 infected cells were epithelial cells. Primary
endocervical epithelial cells were co-cultured with (A) HIV-1/XMRV co-infected CEMX174; (B) same as (A) in presence of AZT; (C) HIV-1 infected
CEMx174; (D) XMRV infected CEMx174; (E) mock infected CEMx174.
doi:10.1371/journal.pone.0101367.g008
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barrier to virus entry. Our results confirmed that primary female
genital epithelial cells are not susceptible to infection by WT HIV-
1. However, when co-produced with a second virus with tropism
for epithelial cells, progeny HIV-1 were able to infect primary
vaginal and endocervical epithelial cells. These results were highly
reproducible and indicate that natural pseudotyping of HIV-1 has
the potential to drastically increase the risk of sexual transmission
by rendering the virus capable of infecting genital epithelial cells
that normally serve as barriers to virus entry. A number of factors
can substantially increase the risk of sexual transmission of HIV-1,
including mucosal ulceration, inflammation, and pre-existing
sexually transmitted infections. The increase in risk of infection
associated with these conditions maybe stochastic; i.e., increased
numbers of HIV-1-susceptible cells in the genital tract resulting in
increased likelihood that virus particles will find a target cell to
infect [70–72]. In the case of a naturally pseudotyped HIV-1
particle able to infect genital epithelial cells directly, particularly
endocervical cells, increased risk of transmission would not
necessarily depend on any of the above factors. The risk of
infection for each exposure to pseudotyped HIV-1 may be quite
high. Once HIV-1 has infected genital epithelial cells it would
revert back to its WT tropism since it acquires the heterologous
viral envelope protein but not its gene during natural pseudotyp-
ing. The HIV-1-infected epithelial cells could spread the virus to
intraepithelial T cells, macrophages or dendritic cells that are
normally present in genital tissues and this would then result in
systemic infection after these cells migrate to lymphoid tissues [73–
75]. Interestingly, others have shown that epithelial cells infected
with HIV-1 and other pathogenic viruses release proinflammatory
cytokines [76–78]. Thus it is possible that after infection of genital
epithelial cells by pseudotyped HIV-1 and or the second epithelial-
tropic virus from the transmitting host, release of such factors
would result in influx of HIV-1-susceptible T cells and macro-
phages thereby increasing the likelihood of hematopoietic spread
of the virus.
We used the gammaretrovirus XMRV as the model virus for
proving that natural pseudotyping could result in infection of
primary genital cells by HIV-1. At the time our work began
XMRV was thought to be a potential human pathogen but
subsequent studies disproved this notion [25] and it is unlikely that
XMRV is relevant to HIV-1 biology in humans [79]. However,
the majority of individuals infected with HIV-1 are co-infected by
one of several other pathogenic viruses including HTLV I/II
[18,80], HBV, HCV [19,81], GBV-C [21], HCMV [82], HHV-
6/7/8, EBV [83], and HSV-1/2 [22,84]. As noted above, in vitro
studies have shown that HIV-1 can be pseudotyped with envelope
glycoproteins from several of these viruses [50,57–59]. Also, recent
publications show that human endogenous retroviruses (HERV)
can be activated after HIV-1 infection [85,86] and it has been
demonstrated that HIV-1 can be pseudotyped by a HERV
glycoprotein [87]. It is noteworthy that many of these pathogenic
viruses, including HCMV and HTLV, have a tropism that
overlaps with that of HIV-1 and they are able to infect T cells and
or macrophages [88–91]. Thus it is possible that natural
pseudotyping of HIV-1 occurs in vivo, especially in regions with
high prevalence of other human pathogenic viruses. In southern
Africa and other regions of the world with high HIV-1
transmission rates, prevalence of viruses such as HTLV-1/2 and
CMV is also high [18,80,82,92–94]. Natural pseudotyping of
HIV-1 with glycoproteins from these viruses may be one of several
factors responsible for high HIV-1 transmission rates. Natural
pseudotyping may also be a factor in transmission of HIV-1 by so-
called ‘‘superspreaders’’ since co-infection with other sexually
transmitted viruses and other pathogens has been shown in HIV-1
superspreaders [8,70,71]. Interestingly, a past study reported that
co-infection with HTLV can affect disease progression in HIV-1
infected patients [80]. The expanded tropism of HIV-1 as a
consequence of pseudotyping and infection of non-hematopoietic
cells could possibly explain, at least in part, changes in disease
progression in HIV-1/HTLV co-infected individuals. The ability
of HIV-1 to change its tropism by acquiring glycoproteins from
other viruses or endogenous retroviruses could also explain
published reports of infection of non-CD4+ cells in vivo, including
epithelial cells and hepatocytes [95–98]. Interestingly, there have
been reports that efforts to reduce the prevalence of HSV also
resulted in lower infection rates of HIV-1 [99,100].
This work has potentially important implications for sexual
transmission of HIV-1. The mechanisms involved in sexual
transmission of HIV-1 remain unclear. There is no evidence of
direct infection of genital epithelial cells by HIV-1 as a mode of
viral transmission. There is also no evidence proving otherwise
and an increasing number of reports indicate that epithelial cells
from genital and other tissues can be infected by the virus [95–98].
As noted above, very low frequency infection of epithelial cells by
pseudotyped HIV-1 could result in rapid spread to intraepithelial
hematopoietic cells. So it is possible that an apparent transmission
event involving CD4+ cells actually resulted from an initial
infection of epithelial cells. We suggest that natural pseudotyping
could play an important role in HIV-1 transmission in some
settings and warrants further investigation.
Supporting Information
Figure S1 Pseudotpyed HIV-1 infects epithelial cells
derived from the cervix. Immunofluorescence analysis of
HIV-1 infection in Ect1/E6E7 (A, C) and End1/E6E7 (B, D) cells.
Ect1/E6E7 and End1/E6E7 cells were infected with progeny virus
from primary CD4+ T cells or CEMX174 and were stained for
HIV-1 Gag expression 5 days post-infection. The input virus used
to infect producer T cells are as indicated; target epithelial cells
exposed to progeny viruses in presence of AZT are indicated on
the panels (shown in (C) and (D)). An enlarged view of epithelial
cells exposed to progeny virus from HIV-1/XMRV co-infected
CEMX174 cells is shown (second panel of A, B). HIV-1 Gag
expression is indicated by green fluorescence (FITC); green
fluorescence merged to the corresponding bright field image is
shown in the bottom panels. Data shown are representative of six
independent experiments. Bar = 10 mm.
(TIF)
Figure S2 HIV-1 infection of HeLa cells and neutralizing
activity of 2F5 MAb. (A) Quantifying HIV-1 infection in HeLa
cells. HeLa cells were exposed to progeny virus from CEMx174
cells infected with HIV alone (HIV-1), XMRV alone (XMRV) or
co-infected with both (HIV/XMRV). Supernatant from uninfect-
ed CEMx174 cells (mock) was used as a control. Immunofluores-
cence staining and flow cytometry analysis were then performed
with FITC-anti-HIV-1 Gag MAb. HeLa cells were also exposed to
infected by the progeny virus from HIV/XMRV co-infected cells
in presence of AZT (second panel). (B) The neutralizing activity of
2F5 antibody against HIV-1 was confirmed by exposing TZM-bl
cells to HIV-1 in the presence of dilutions of the antibody.
Infection was assessed after 2 days by measuring luciferase activity
as described in Materials and Methods.
(TIF)
Figure S3 Isolation and characterization of primary
cervical and vaginal epithelial cells. (A) Representative
image to show epithelial cells migrating from tissue explants after 5
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days of culture. Endocervix (B) and vagina (C) derived epithelial
cells formed monolayers after 7 days of culture. D, E, F, G: The
epithelial cells from endocervix (D, F) or vagina and ectocervix (E,
G respectively) were subjected to immunofluorescence staining
for the indicated protein as described in Materials and Methods.
(TIF)
Figure S4 Visualization of R5 strain HIV-1Bal infection
of primary endocervical epithelial cells. Dual immunoflu-
orescence staining with FITC-anti-HIV-1 Gag and anti-CK19
Mabs was performed in primary endocervical epithelial cells that
were exposed to progeny virus from infected CEMx174 cells. The
input viruses used to infect CEMx174 cells are indicated
(HIV=HIV alone; XMRV=XMRV alone; HIV/XMRV=co-
infected with both). Epithelial cells exposed to progeny virus in
presence of AZT or anti-MLV polyclonal sera diluted 1:300 are
shown as indicated (B, left two columns). HIV-1 Gag is shown as
green and CK19 as red. Green fluorescence merged to the
corresponding bright field is shown in (A).
(TIF)
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